The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE

OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8

COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ATARA BIOTHERAPEUTICS INC COM 046513107 291 9,260 SH   SOLE 0 9,260 0 0
CORCEPT THERAPEUTICS INC COM 218352102 84 22,334 SH   SOLE 0 22,334 0 0
ISHARES FTSE/XINHUA CHINA 25 INDEX FUND COM 296074305 95,900 2,703,700 SH   SOLE 0 2,703,700 0 0
JPMORGAN CHASE & CO ETF 464287465 244 4,000 SH   SOLE 0 4,000 0 0
PALO ALTO NETWORKS INC COM 46121H109 5,835 33,927 SH   SOLE 0 33,927 0 0
TESARO INC COM 46333X108 250 6,238 SH   SOLE 0 6,238 0 0
I SHARES MSCI EAFE INDEX FD COM 464287184 108,645 1,895,400 SH   SOLE 0 1,895,400 0 0
VANGUARD MSCI EMERGING MARKETS ETF ETF 46625H100 112,837 3,410,000 SH   SOLE 0 3,410,000 0 0